ACLY and cardiovascular disorder: Genetic variants that mimic the effect of ATP citrate lyase inhibitors and statins appeared to lower plasma LDL-C levels by the same mechanism of action and were associated with similar decreased risk of cardiovascular disease per unit decrease in the LDL-C level [32].